Oppenheimer analyst Jay Olson downgrades Relmada Therapeutics (NASDAQ:RLMD) from Outperform to Perform.
$1000 Invested In Micron Technology 10 Years Ago Would Be Worth This Much Today
Micron Technology (NASDAQ:MU) has outperformed the market over the past 10 years by 14.01% on an annualized basis producing an average annual return of 25.11%. Currently, Micron Technology has a market capitalization of $63.16 billion.
